35
Event Line
FDA asks Pfizer to test second Paxlovid course in patients with COVID rebound
Axsome surges after oral depression drug gets FDA approval
From FDA:FDA Approves First Cell-Based Gene Therapy to Treat Adult and Pediatric Patients with Beta-thalassemia Who Require Regular Blood Transfusions
Bayer gets FDA nod to extend use of popular contraceptive IUD Mirena
FDA approves Zynteglo gene therapy for beta-thalassemia patients
Bluebird's $2.8 mln gene therapy for rare blood disorder gets FDA approval
FDA approves one of the priciest new treatments of all time — bluebirds gene therapy for beta thalassemia
FDA accepts Roche’s sBLA for combination therapy to treat DLBCL
FDA grants priority review to Lynparza combo therapy for metastatic prostate cancer
Roche announces U.S. FDA approval of Xofluza to treat influenza in children aged five years and older
2026-07-04
Related Topic
# FDA
